IBDEI080 ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10652,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10652,1,4,0)
 ;;=4^396.3
 ;;^UTILITY(U,$J,358.3,10652,1,5,0)
 ;;=5^Aortic And Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,10652,2)
 ;;=Aortic and Mitral Insufficiency^269583
 ;;^UTILITY(U,$J,358.3,10653,0)
 ;;=414.3^^69^681^17
 ;;^UTILITY(U,$J,358.3,10653,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10653,1,4,0)
 ;;=4^414.3
 ;;^UTILITY(U,$J,358.3,10653,1,5,0)
 ;;=5^CAD d/t Lipid Rich Plaque
 ;;^UTILITY(U,$J,358.3,10653,2)
 ;;=^336601
 ;;^UTILITY(U,$J,358.3,10654,0)
 ;;=453.9^^69^681^82
 ;;^UTILITY(U,$J,358.3,10654,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10654,1,4,0)
 ;;=4^453.9
 ;;^UTILITY(U,$J,358.3,10654,1,5,0)
 ;;=5^Venous Thrombosis NOS
 ;;^UTILITY(U,$J,358.3,10654,2)
 ;;=^39455
 ;;^UTILITY(U,$J,358.3,10655,0)
 ;;=453.89^^69^681^1
 ;;^UTILITY(U,$J,358.3,10655,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10655,1,4,0)
 ;;=4^453.89
 ;;^UTILITY(U,$J,358.3,10655,1,5,0)
 ;;=5^AC Venous Embolism NEC
 ;;^UTILITY(U,$J,358.3,10655,2)
 ;;=^338259
 ;;^UTILITY(U,$J,358.3,10656,0)
 ;;=453.79^^69^681^27
 ;;^UTILITY(U,$J,358.3,10656,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10656,1,4,0)
 ;;=4^453.79
 ;;^UTILITY(U,$J,358.3,10656,1,5,0)
 ;;=5^Chr Venous Embolism NEC
 ;;^UTILITY(U,$J,358.3,10656,2)
 ;;=^338251
 ;;^UTILITY(U,$J,358.3,10657,0)
 ;;=425.11^^69^681^55
 ;;^UTILITY(U,$J,358.3,10657,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10657,1,4,0)
 ;;=4^425.11
 ;;^UTILITY(U,$J,358.3,10657,1,5,0)
 ;;=5^Hypertrophic Subaortic Stenosis
 ;;^UTILITY(U,$J,358.3,10657,2)
 ;;=^340520
 ;;^UTILITY(U,$J,358.3,10658,0)
 ;;=425.18^^69^681^61
 ;;^UTILITY(U,$J,358.3,10658,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10658,1,4,0)
 ;;=4^425.18
 ;;^UTILITY(U,$J,358.3,10658,1,5,0)
 ;;=5^Oth Hypertrophic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,10658,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,10659,0)
 ;;=V12.55^^69^681^50
 ;;^UTILITY(U,$J,358.3,10659,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10659,1,4,0)
 ;;=4^V12.55
 ;;^UTILITY(U,$J,358.3,10659,1,5,0)
 ;;=5^Hx of Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,10659,2)
 ;;=^340615
 ;;^UTILITY(U,$J,358.3,10660,0)
 ;;=414.4^^69^681^16
 ;;^UTILITY(U,$J,358.3,10660,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10660,1,4,0)
 ;;=4^414.4
 ;;^UTILITY(U,$J,358.3,10660,1,5,0)
 ;;=5^CAD d/t Calc Coronary Lesion
 ;;^UTILITY(U,$J,358.3,10660,2)
 ;;=^340518
 ;;^UTILITY(U,$J,358.3,10661,0)
 ;;=271.3^^69^682^17
 ;;^UTILITY(U,$J,358.3,10661,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10661,1,4,0)
 ;;=4^271.3
 ;;^UTILITY(U,$J,358.3,10661,1,5,0)
 ;;=5^Glucose Intolerance
 ;;^UTILITY(U,$J,358.3,10661,2)
 ;;=^64790
 ;;^UTILITY(U,$J,358.3,10662,0)
 ;;=611.1^^69^682^22
 ;;^UTILITY(U,$J,358.3,10662,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10662,1,4,0)
 ;;=4^611.1
 ;;^UTILITY(U,$J,358.3,10662,1,5,0)
 ;;=5^Gynecomastia
 ;;^UTILITY(U,$J,358.3,10662,2)
 ;;=^60454
 ;;^UTILITY(U,$J,358.3,10663,0)
 ;;=704.1^^69^682^23
 ;;^UTILITY(U,$J,358.3,10663,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10663,1,4,0)
 ;;=4^704.1
 ;;^UTILITY(U,$J,358.3,10663,1,5,0)
 ;;=5^Hirsutism
 ;;^UTILITY(U,$J,358.3,10663,2)
 ;;=^57407
 ;;^UTILITY(U,$J,358.3,10664,0)
 ;;=251.2^^69^682^36
 ;;^UTILITY(U,$J,358.3,10664,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10664,1,4,0)
 ;;=4^251.2
 ;;^UTILITY(U,$J,358.3,10664,1,5,0)
 ;;=5^Hypoglycemia Nos
 ;;^UTILITY(U,$J,358.3,10664,2)
 ;;=^60580
 ;;^UTILITY(U,$J,358.3,10665,0)
 ;;=257.2^^69^682^37
 ;;^UTILITY(U,$J,358.3,10665,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10665,1,4,0)
 ;;=4^257.2
 ;;^UTILITY(U,$J,358.3,10665,1,5,0)
 ;;=5^Hypogonadism,Male
 ;;^UTILITY(U,$J,358.3,10665,2)
 ;;=^88213
 ;;^UTILITY(U,$J,358.3,10666,0)
 ;;=253.2^^69^682^41
 ;;^UTILITY(U,$J,358.3,10666,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10666,1,4,0)
 ;;=4^253.2
 ;;^UTILITY(U,$J,358.3,10666,1,5,0)
 ;;=5^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,10666,2)
 ;;=^60686
 ;;^UTILITY(U,$J,358.3,10667,0)
 ;;=733.00^^69^682^52
 ;;^UTILITY(U,$J,358.3,10667,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10667,1,4,0)
 ;;=4^733.00
 ;;^UTILITY(U,$J,358.3,10667,1,5,0)
 ;;=5^Osteoporosis Nos
 ;;^UTILITY(U,$J,358.3,10667,2)
 ;;=^87159
 ;;^UTILITY(U,$J,358.3,10668,0)
 ;;=278.00^^69^682^48
 ;;^UTILITY(U,$J,358.3,10668,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10668,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,10668,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,10668,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,10669,0)
 ;;=278.01^^69^682^47
 ;;^UTILITY(U,$J,358.3,10669,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10669,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,10669,1,5,0)
 ;;=5^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,10669,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,10670,0)
 ;;=250.80^^69^682^15
 ;;^UTILITY(U,$J,358.3,10670,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10670,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,10670,1,5,0)
 ;;=5^DM Type II W/ LE Ulcer
 ;;^UTILITY(U,$J,358.3,10670,2)
 ;;=DM Type II with LE Ulcer^267846^707.10
 ;;^UTILITY(U,$J,358.3,10671,0)
 ;;=250.00^^69^682^9
 ;;^UTILITY(U,$J,358.3,10671,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10671,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,10671,1,5,0)
 ;;=5^DM Type II  W/O Complications
 ;;^UTILITY(U,$J,358.3,10671,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,10672,0)
 ;;=250.40^^69^682^11
 ;;^UTILITY(U,$J,358.3,10672,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10672,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,10672,1,5,0)
 ;;=5^DM Type II W/ Nephropathy
 ;;^UTILITY(U,$J,358.3,10672,2)
 ;;=^267837^583.81
 ;;^UTILITY(U,$J,358.3,10673,0)
 ;;=250.50^^69^682^14
 ;;^UTILITY(U,$J,358.3,10673,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10673,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,10673,1,5,0)
 ;;=5^DM Type II W/ PDR
 ;;^UTILITY(U,$J,358.3,10673,2)
 ;;=DM Type II w/ PDR^267839^362.02
 ;;^UTILITY(U,$J,358.3,10674,0)
 ;;=250.60^^69^682^12
 ;;^UTILITY(U,$J,358.3,10674,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10674,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,10674,1,5,0)
 ;;=5^DM Type II W/ Neuropathy
 ;;^UTILITY(U,$J,358.3,10674,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,10675,0)
 ;;=250.70^^69^682^13
 ;;^UTILITY(U,$J,358.3,10675,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10675,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,10675,1,5,0)
 ;;=5^DM Type II W/ Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,10675,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,10676,0)
 ;;=250.01^^69^682^8
 ;;^UTILITY(U,$J,358.3,10676,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10676,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,10676,1,5,0)
 ;;=5^DM Type I  W/O Complications
 ;;^UTILITY(U,$J,358.3,10676,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,10677,0)
 ;;=272.0^^69^682^28
 ;;^UTILITY(U,$J,358.3,10677,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10677,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,10677,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,10677,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,10678,0)
 ;;=272.1^^69^682^33
 ;;^UTILITY(U,$J,358.3,10678,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10678,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,10678,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,10678,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,10679,0)
 ;;=272.2^^69^682^30
 ;;^UTILITY(U,$J,358.3,10679,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10679,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,10679,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,10679,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,10680,0)
 ;;=275.42^^69^682^27
 ;;^UTILITY(U,$J,358.3,10680,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10680,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,10680,1,5,0)
 ;;=5^Hypercalcaemia
 ;;^UTILITY(U,$J,358.3,10680,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,10681,0)
 ;;=275.41^^69^682^35
 ;;^UTILITY(U,$J,358.3,10681,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10681,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,10681,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,10681,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,10682,0)
 ;;=276.7^^69^682^29
 ;;^UTILITY(U,$J,358.3,10682,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10682,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,10682,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,10682,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,10683,0)
 ;;=275.2^^69^682^25
 ;;^UTILITY(U,$J,358.3,10683,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10683,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,10683,1,5,0)
 ;;=5^Hyper or Hypomagnesaemia
 ;;^UTILITY(U,$J,358.3,10683,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,10684,0)
 ;;=276.0^^69^682^31
 ;;^UTILITY(U,$J,358.3,10684,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10684,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,10684,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,10684,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,10685,0)
 ;;=276.1^^69^682^38
 ;;^UTILITY(U,$J,358.3,10685,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10685,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,10685,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,10685,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,10686,0)
 ;;=275.3^^69^682^26
 ;;^UTILITY(U,$J,358.3,10686,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10686,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,10686,1,5,0)
 ;;=5^Hyper or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,10686,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,10687,0)
 ;;=240.0^^69^682^20
 ;;^UTILITY(U,$J,358.3,10687,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10687,1,4,0)
 ;;=4^240.0
 ;;^UTILITY(U,$J,358.3,10687,1,5,0)
 ;;=5^Goiter, Simple
 ;;^UTILITY(U,$J,358.3,10687,2)
 ;;=^259806
 ;;^UTILITY(U,$J,358.3,10688,0)
 ;;=241.1^^69^682^19
 ;;^UTILITY(U,$J,358.3,10688,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10688,1,4,0)
 ;;=4^241.1
 ;;^UTILITY(U,$J,358.3,10688,1,5,0)
 ;;=5^Goiter, Nontox, Multinod
 ;;^UTILITY(U,$J,358.3,10688,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,10689,0)
 ;;=241.0^^69^682^59
